title: Combined gene expression and protein interaction analysis of dynamic modularity in glioma prognosis.
abstract: Because of the variety of factors affecting glioma prognosis, prediction of patient survival is particularly difficult. Protein-protein interaction (PPI) networks have been considered with regard to how their spatial characteristics relate to glioma. However, the dynamic nature of PPIs in vivo makes them temporally and spatially complex events. Integration of prognosis-specific co-expression information adds further dynamic features to these networks. Although some biomarkers for glioma prognosis have been identified, none is sufficient for accurate prediction of either prognosis or improved survival. We have established co-expressed protein-interaction networks that integrate protein-protein interactions with glioma gene-expression profiles related to different survival times. Biomarkers related to glioma prognosis were identified by comparative analysis of the dynamic features of the glioma prognosis network, particularly subnetworks. Four significantly differently expressed genes (SDEGs) are upregulated and ten SDEGs downregulated as lifetime is extended. In addition, 97 enhanced differently co-expressed protein interactions (DCPIs) and 99 weakened DCPIs were associated with glioma patient lifetime extension. We propose a method for estimating glioma prognosis on the basis of the construction of a dynamic modular network. We have used this method to identify dynamic genes and interactions related to glioma prognosis. Among these, enhanced MYC expression was related to lifetime extension, as were interactions between E2F1 and RB1 and between EGFR and p38. This method is a novel means of studying the molecular mechanisms determining prognosis in glioma.
authors.affiliation: Department of Neurosurgery, The Second Affiliated Hospital, Harbin Medical University, Harbin, China.
authors.forename: Xiaoyu
authors.initials: X
authors.lastname: Zhang
authors.forename: Hongbin
authors.initials: H
authors.lastname: Yang
authors.forename: Binsheng
authors.initials: B
authors.lastname: Gong
authors.forename: Chuanlu
authors.initials: C
authors.lastname: Jiang
authors.forename: Lizhuang
authors.initials: L
authors.lastname: Yang
mesh_terms: D015415:Biomarkers; D001932:Brain Neoplasms / Q000175:diagnosis* / Q000378:metabolism; D019295:Computational Biology; D015870:Gene Expression / Q000502:physiology*; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D005910:Glioma / Q000175:diagnosis* / Q000378:metabolism; D006801:Humans; D008954:Models, Biological; D017711:Nonlinear Dynamics; D011379:Prognosis; D025941:Protein Interaction Mapping
chemical_list: D015415:Biomarkers
references.citation: Oncol Rep. 2006 Nov;16(5):1093-8
references.pmid: 17016598
references.citation: Expert Rev Proteomics. 2011 Feb;8(1):61-79
references.pmid: 21329428
references.citation: N Engl J Med. 2009 May 21;360(21):2248; author reply 2249
references.pmid: 19458374
references.citation: J Surg Res. 2011 Jun 1;168(1):97-102
references.pmid: 20036387
references.citation: BMC Cancer. 2010 Aug 10;10:415
references.pmid: 20696081
references.citation: BMC Syst Biol. 2010 Nov 09;4:151
references.pmid: 21059271
references.citation: Mod Pathol. 2010 Apr;23(4):619-28
references.pmid: 20081802
references.citation: Pac Symp Biocomput. 2009;:203-14
references.pmid: 19209702
references.citation: Cancer Res. 2007 Jul 1;67(13):6121-9
references.pmid: 17616668
references.citation: J Physiol. 2006 Sep 1;575(Pt 2):373-7
references.pmid: 16840513
references.citation: Am J Physiol Cell Physiol. 2009 Nov;297(5):C1284-93
references.pmid: 19692652
references.citation: J Neurooncol. 1997 Oct;35(1):13-28
references.pmid: 9266437
references.citation: Science. 2002 Oct 25;298(5594):799-804
references.pmid: 12399584
references.citation: Cancer Res. 2011 Jul 1;71(13):4550-61
references.pmid: 21555372
references.citation: Cancer Res. 2001 Mar 1;61(5):1825-9
references.pmid: 11280731
references.citation: Brain Res. 2011 May 19;1391:125-31
references.pmid: 21439273
references.citation: Oncol Rep. 2006 Jun;15(6):1569-74
references.pmid: 16685397
references.citation: Nucleic Acids Res. 2003 Feb 15;31(4):e15
references.pmid: 12582260
references.citation: Science. 1998 Jan 16;279(5349):349-52
references.pmid: 9454332
references.citation: Biochim Biophys Acta. 2001 Mar 19;1518(1-2):1-6
references.pmid: 11267653
references.citation: BMC Bioinformatics. 2005 May 29;6:129
references.pmid: 15921534
references.citation: N Engl J Med. 2005 Mar 10;352(10):997-1003
references.pmid: 15758010
references.citation: J Neurooncol. 2009 Sep;94(2):213-9
references.pmid: 19337694
references.citation: Nat Biotechnol. 2009 Feb;27(2):199-204
references.pmid: 19182785
references.citation: Brain Pathol. 2002 Jan;12(1):108-16
references.pmid: 11771519
references.citation: Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21
references.pmid: 11309499
references.citation: Nat Genet. 2007 Jun;39(6):750-8
references.pmid: 17468755
references.citation: Clin Cancer Res. 2000 Apr;6(4):1239-47
references.pmid: 10778946
references.citation: Bioinformatics. 2005 May 1;21(9):2076-82
references.pmid: 15657099
references.citation: Cancer Cell. 2006 Mar;9(3):157-73
references.pmid: 16530701
references.citation: Nature. 2006 Jun 15;441(7095):840-6
references.pmid: 16699522
references.citation: Surg Neurol. 2005 Oct;64(4):286-94; discussion 294
references.pmid: 16229087